A new leadership duo strengthens Oslo Cancer Cluster (OCC) Incubator, as General Manager Bjørn Klem steps down after six years.
“Six years as general manager of OCC Incubator has been a fantastic journey. We have moved from a small office in Lysaker to a dream come true in a building housing an entire innovation system for startups and enterprises next to the Radium Hospital in Oslo,” says Bjørn Klem, soon-to-be-former general manager of Oslo Cancer Cluster (OCC) Incubator.
Janne Nestvold, Chief Operating Officer
Janne Nestvold, who has built several impressive laboratories over the last years, will become the new Chief Operating Officer. Nestvold is currently laboratory manager at OCC Incubator. She holds a PhD in Immunology from the Faculty of Medicine at the University of Oslo. Her research experience is from academia and biotech companies within the field of immuno-oncology.
“The OCC Incubator team is grateful to Bjørn Klem for his supportive and open-minded leadership. I am enthusiastic to further develop OCC Incubator and continue Klem’s solid work in the organization,” says Nestvold, new Chief Operating Officer (COO) in OCC Incubator.
Ketil Widerberg, Chief Executive Officer
Ketil Widerberg steps in as the new Chief Executive Officer (CEO) of OCC Incubator, bringing seven years of experience as general manager of Oslo Cancer Cluster. Widerberg will continue as general manager of Oslo Cancer Cluster, while leading OCC Incubator in partnership with Nestvold. Widerberg is also Chairman of the Board at Oslo Cancer Cluster Incubator.
“OCC Incubator has become increasingly important in the development of a rich cluster environment with strong start-ups in OCC Innovation Park. For the start-ups in the incubator, closeness to larger private companies and public institutions, through the cluster, is essential. This is why I think our new organization is ideal right now,” says Widerberg.
Leading a start-up
Klem will be the new CEO of AdjuTec Pharma, a Norwegian pharmaceutical start-up developing a new technology to combat antibiotic resistance, from 1 July.
“I am happy to say AdjuTec Pharma is a true product of the Accelerator programme. I will still have my office space in OCC Incubator and be part of the Accelerator programme as the head of a start-up,” Klem says. “Finally, I want to thank the team and partners for unforgettable years at OCC Incubator. And I hope I will still get a homemade bun from the students with the baking project at Ullern Upper Secondary School every Friday.”
Photo of Janne Nestvold and Ketil Widerberg: Oslo Cancer Cluster/Stig Jarnes